1: Suárez D, Díaz N. Conformational and entropy analyses of extended molecular
dynamics simulations of α-, β- and γ-cyclodextrins and of the
β-cyclodextrin/nabumetone complex. Phys Chem Chem Phys. 2017 Jan
4;19(2):1431-1440. doi: 10.1039/c6cp06107a. PubMed PMID: 27982145.
<br>
2: Goodwin DJ, Martini LG, Lawrence MJ. Production of nabumetone nanoparticles:
Effect of molecular weight, concentration and nature of cellulose ether
stabiliser. Int J Pharm. 2016 Dec 5;514(2):428-444. doi:
10.1016/j.ijpharm.2016.09.079. Epub 2016 Sep 29. PubMed PMID: 27693736.
<br>
3: Balap A, Lohidasan S, Sinnathambi A, Mahadik K. Pharmacokinetic and
Pharmacodynamic Interaction of Andrographolide and Standardized Extract of
Andrographis paniculata (Nees) with Nabumetone in Wistar Rats. Phytother Res.
2017 Jan;31(1):75-80. doi: 10.1002/ptr.5731. Epub 2016 Oct 7. PubMed PMID:
27714886.
<br>
4: Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH. Nabumetone use and risk of
acute pancreatitis in a case-control study. Pancreatology. 2016
May-Jun;16(3):353-7. doi: 10.1016/j.pan.2016.03.003. Epub 2016 Mar 11. PubMed
PMID: 27029853.
<br>
5: Asadi M, Haji Shabani AM, Dadfarnia S, Abbasi B. Vortex-assisted
surfactant-enhanced emulsification microextraction based on solidification of
floating organic drop combined with high performance liquid chromatography for
determination of naproxen and nabumetone. J Chromatogr A. 2015 Dec 18;1425:17-24.
doi: 10.1016/j.chroma.2015.11.005. Epub 2015 Nov 19. PubMed PMID: 26627589.
<br>
6: Světlík S, Štícha M, Matoušková O, Nespěšná L, Sklenář Z, Bartůněk A, Perlík
F, Slanař O. Nabumetone and 6-MNA Pharmacokinetics, Assessment of Intrasubject
Variability and Gender Effect. Am J Ther. 2016 Nov/Dec;23(6):e1498-e1503. PubMed
PMID: 25393072.
<br>
7: Matsumoto K, Hasegawa T, Koyanagi J, Takahashi T, Akimoto M, Sugibayashi K.
Reductive metabolism of nabumetone by human liver microsomal and cytosolic
fractions: exploratory prediction using inhibitors and substrates as marker
probes. Eur J Drug Metab Pharmacokinet. 2015 Jun;40(2):127-35. PubMed PMID:
24659525.
<br>
8: Varfaj F, Zulkifli SN, Park HG, Challinor VL, De Voss JJ, Ortiz de Montellano
PR. Carbon-carbon bond cleavage in activation of the prodrug nabumetone. Drug
Metab Dispos. 2014 May;42(5):828-38. doi: 10.1124/dmd.114.056903. Epub 2014 Feb
28. PubMed PMID: 24584631; PubMed Central PMCID: PMC3989788.
<br>
9: Česlová L, Holčapek M, Nobilis M. Identification of combined conjugation of
nabumetone phase I metabolites with glucuronic acid and glycine in minipig
biotransformation using coupling high-performance liquid chromatography with
electrospray ionization mass spectrometry. J Pharm Biomed Anal. 2014
Jan;88:221-4. doi: 10.1016/j.jpba.2013.08.053. Epub 2013 Sep 12. PubMed PMID:
24083957.
<br>
10: Perez-Ezquerra PR, Sanchez-Morillas L, Laguna Martinez JJ, Gonzalez Mendiola
R, Gomez-Traseira C, Carrasco Garcia I, Herranz Mañas M, Rubio Matos A.
Hypersensitivity to nabumetone: cross reactivity with naproxen. Ann Allergy
Asthma Immunol. 2013 Jul;111(1):74-5. doi: 10.1016/j.anai.2013.05.006. PubMed
PMID: 23806470.
|